2003 Saab 9-5 Aero Wagon Silver/black Interior on 2040-cars

Auto blog

1999 Saab 9-3 Viggen is a Swede worth remembering on MotorWeek

Today, Saab survives in name only after a protracted series of bankruptcies and attempted comebacks with new owners. At the turn of the millennium, however, the brand was still able to make some great cars, though. MotorWeek is showing off one of its very best in this vintage review for the 1999 9-3 Viggen. The jet-inspired Viggen was the pinnacle of everything Saab's engineers could do at the time. Starting with the standard 9-3, the suspension was hunkered down to improve handling and lower bodywork was added for better aerodynamics. Now that the exterior looked the part, the 2.3-liter turbocharged four-cylinder was tweaked to make 225 horsepower and 252 pound-feet of torque. While that output may not sound hugely impressive by modern standards, those were strong numbers in the day, and the following model year made even more power. After some time behind the wheel of the VIggen, MotorWeek came away quite impressed with this Swede. While the Viggen might not have offered the full capability of high-performance, European contemporaries like the BMW M3, Saab really showed its strengths with this model.

GM recalls 500K Chevy Camaros for ignition-switch defect

General Motors issued a recall for more than a half million Chevrolet Camaros on Friday morning because of an ignition-switch safety hazard that mirrors the one at the center of the company's current crisis.
The problem affects Camaro models from the 2010 to 2014 model years. Approximately 464,712 cars are impacted in the United States, and 511,528 overall in North America. GM will alter the Camaro key to a more standard design, and will notify car owners with a recall notice in the mail.
In an announcement, the company said the ignition switches on the Camaros are fundamentally different parts than the older ignition switches found on defective cars that are responsible for killing at least 13 people and causing 54 crashes.

NEVS, the company that took over Saab, gets new majority owner

Chinese real estate conglomerate Evergrande Group, a key investor behind troubled electric vehicle startup Faraday Future, has acquired a 51 percent stake in NEVS. That's the Chinese-backed Swedish electric vehicle company that purchased the assets of Saab out of bankruptcy in 2012. The investment by subsidiary Evergrande Health Industry Group was valued at the equivalent of $930 million and is expected to help NEVS develop new EVs. Evergrande said it paid the first installment of $430 million on Jan. 15, with the remainder due by the end of the month. The remaining 49 percent stake is controlled by a holding company controlled by NEVS founder Kai Johan Jiang. "It means that NEVS will get a financial (sic) strong main owner who is very interested in developing our vision about green mobility transport solutions for the future," NEVS CEO Stefan Tilk said in a statement. NEVS, short for National Electric Vehicle Sweden, owns production facilities in Trollhattan, Sweden, and Tianjin, China, with another under construction in Shanghai. In late 2017 the company launched what apparently was limited production of the 9-3 EV, an electric vehicle based — you guessed it — on the old Saab 9-3 platform. The company now says it will be built in Tianjin starting later this year, with components coming from Trollhattan. It boasts a 186-mile range, in-car WiFi and a cabin air filter for the notoriously smoggy Chinese air. It also showed a battery-electric 9-3X concept at CES Asia in 2017, which is likely to be its next model pegged for production. The South China Morning Post, citing local media reports, says two of NEVS' models meet the standards for mass production in China. This content is hosted by a third party. To view it, please update your privacy preferences. Manage Settings. Definitely the best promotional video we've ever seen. Evergrande Health first came to Faraday Future's rescue back in 2017 with a promised $2 billion investment, but the two sides later went into arbitration in Hong Kong over a dispute about money following the first infusion of $800 million, leading the automaker to cut staff and wages last year, casting the future of FF into doubt. At the end of 2018, Faraday announced it had entered into a new restructuring agreement with an Evergrande Health subsidiary that sees them end litigation and jettison the previous investment agreement, taking Evergrande's investment in the company to 32 percent.